Theravance Biopharma (TBPH) Divestments (2020 - 2022)
Theravance Biopharma (TBPH) posted quarterly Divestments of -$1.1 billion for Q4 2022, down 7416.0% quarter-over-quarter from $14.9 million in Q1 2020.
Theravance Biopharma (TBPH) Divestments (2020 - 2022) Analysis & Trends
Theravance Biopharma (TBPH) has reported Divestments for 2 consecutive years, with -$1.1 billion the latest figure, recorded in Q4 2022.
- In Q4 2022, Divestments changed N/A year-over-year to -$1.1 billion; the TTM figure through Dec 2022 stood at -$1.1 billion (changed N/A YoY), while the FY2022 annual figure was $2.7 million, changed N/A from the prior year.
- Divestments retreated to -$1.1 billion in Q4 2022 per TBPH's latest filing, from $14.9 million in the prior quarter.
- Across five years, Divestments topped out at $14.9 million in Q1 2020 and bottomed at -$1.1 billion in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 9.82 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -13.21 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Theravance Biopharma | 880.59 Mn | 492.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -1.09 Bn |
| Mar 31, 2020 | 14.93 Mn |